Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acasti Pharma (NQ: ACST )

0.8700 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 485
Open 0.8700
Bid (Size) 0.8700 (7)
Ask (Size) 0.9000 (5)
Prev. Close 0.8700
Today's Range 0.8700 - 0.8700
52wk Range 0.3850 - 2.939
Shares Outstanding 44,439,758
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Acasti Pharma Q4 Earnings
Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-36.96%
-36.96%
1 Month
-11.22%
-11.22%
3 Month
-28.10%
-28.10%
6 Month
-29.27%
-29.27%
1 Year
+44.76%
+44.76%

More News

Read More
Earnings Scheduled For June 21, 2022
Via Benzinga
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
Via Benzinga
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
From MicroCap Rodeo
Via AccessWire
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th
From Acasti Pharma Inc.
Via AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast
Via Newsfile
Acasti Pharma's Earnings Outlook
Via Benzinga
Acasti Pharma: Bouncing Back With a New Drug Pipeline
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Earnings Scheduled For February 14, 2022
Via Benzinga
BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
54 Biggest Movers From Thursday
Via Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6
Via InvestorPlace
Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge
Via Benzinga
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge
Via Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
Via Benzinga
See Why Acasti Pharma Shares Are Trading Over 20% Higher?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.